Maternal inheritance of familial hypercholesterolemia caused by the V408M low-density lipoprotein receptor mutation increases mortality

Atherosclerosis

Volumn 219, Issue 2, 2011, Pages 690-693

  Versmissen, Jorie ^a   Botden, Ilse P G ^a   Huijgen, Roeland ^b   Oosterveer, Daniëlla M ^a   Defesche, Joep C ^b   Heil, Thea C ^a   Muntz, Anouk ^a   Langendonk, Janneke G ^a   Schinkel, Arend F L ^a   Kastelein, John J P ^b   Sijbrands, Eric J G ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Coronary heart disease; Familial hypercholesterolemia; Pregnancy; Risk factors

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CONTROLLED STUDY; EXTRACHROMOSOMAL INHERITANCE; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE MUTATION; GENETIC RISK; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PEDIGREE; PRIORITY JOURNAL; STANDARDIZED MORTALITY RATIO; VERTICAL TRANSMISSION;

FATHERS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEREDITY; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE; MOTHERS; MUTATION; NETHERLANDS; PEDIGREE; PHENOTYPE; RECEPTORS, LDL; RISK ASSESSMENT; RISK FACTORS;

EID: 82955189685     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.08.039     Document Type: Article

References (30)

1. Brown M.S., Goldstein J.L. Familial hypercholesterolemia: a genetic defect in the low-density lipoprotein receptor. N Engl J Med 1976, 294:1386-1390.
2. Barker D.J., Gluckman P.D., Godfrey K.M., et al. Fetal nutrition and cardiovascular disease in adult life. Lancet 1993, 341:938-941.
3. Palinski W., Nicolaides E., Liguori A., Napoli C. Influence of maternal dysmetabolic conditions during pregnancy on cardiovascular disease. J Cardiovasc Transl Res 2009, 2:277-285.
4. Napoli C., D'Armiento F.P., Mancini F.P., et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolaemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest 1997, 100:2680-2690.
5. Napoli C., Glass C.K., Witztum J.L., et al. Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study. Lancet 1999, 354:1234-1241.
6. Edison R.J., Muenke M. Mechanistic and epidemiologic considerations in the evaluation of adverse birth outcomes following gestational exposure to statins. Am J Med Genet 2004, 131:287-298.
7. Edison R.J., Muenke M. Central nervous system and limb anomalies in case reports of first-trimester statin exposure. N Engl J Med 2004, 350:1579-1582.
8. Sijbrands E.J., Westendorp R.G., Defesche J.C., et al. Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study. BMJ 2001, 322:1019-1023.
9. Fourie A.M., Coetzee G.A., Gevers W., van der Westhuyzen D.R. Two mutant low-density-lipoprotein receptors in Afrikaners slowly processed to surface forms exhibiting rapid degradation or functional heterogeneity. Biochem J 1988, 255:411-415.
10. Leitersdorf E., Van der Westhuyzen D.R., Coetzee G.A., Hobbs H.H. Two common low denstiy lipoprotein receptor gene mutations cause familial hypercholesterolemia in Afrikaners. J Clin Invest 1989, 84:954-961.
11. Defesche J.C., Lansberg P.J., Reymer P.W., Lamping R.J., Kastelein J.J. Analysis of the Afrikaner mutation in exon 9 of the low-density lipoprotein receptor gene in a large Dutch kindred suffering from familial hypercholesterolaemia. Neth J Med 1993, 42:30-53.
12. Umans-Eckenhausen M.A., Sijbrands E.J., Kastelein J.J., Defesche J.C. Low-density lipoprotein receptor gene mutations and cardiovascular risk in a large genetic cascade screening population. Circulation 2002, 106:3031-3036.
13. Dedoussis G.V., Schmidt H., Genschel J. LDL-receptor mutations in Europe. Hum Mutat 2004, 24:443-459.
14. Tonstad S., Joakimsen O., Leren T.P., Ose L. Does maternal or paternal heredity affect carotid atherosclerosis in children with familial hypercholesterolaemia?. Acta Paediatr 2000, 89:1490-1492.
15. Ward S.D., Melin J.R., Lloyd F.P., Norton J.A., Christian J.C. Determinants of plasma cholesterol in children-a family study. Am J Clin Nutr 1980, 33:63-70.
16. Langenveld J., Lu F., Bytautiene E., et al. In utero programming of vascular function in transgenic mice lacking low-density lipoprotein receptor. Am J Obstet Gynecol 2008, 199:165.e1-165.e5.
17. Napoli C., de Nigris F., Welch J.S., et al. Maternal hypercholesterolemia during pregnancy promotes early atherogenesis in LDL receptor-deficient mice and alters aortic gene expression determined by microarray. Circulation 2002, 105:1360-1367.
18. Alkemade F.E., van Vliet P., Henneman P., et al. Prenatal exposure to apoE deficiency and postnatal hypercholesterolaemia are associated with altered cell-specific lysine methyltransferase and histone methylation patterns in the vasculature. Am J Pathol 2010, 176:542-548.
19. Alkemade F.E., Gittenberger-de Groot A.C., Schiel A.E., et al. Intrauterine exposure to maternal atherosclerotic risk factors increases the susceptibility to atherosclerosis in adult life. Arterioscler Thromb Vasc Biol 2007, 27:2228-2235.
20. DeRuiter M.C., Alkemade F.E., Gittenberger-de Groot A.C., et al. Maternal transmission of risk for atherosclerosis. Curr Opin Lipidol 2008, 19:333-337.
21. Wyne K.L., Woollett L.A. Transport of maternal LDL and HDL to the fetal membranes and placenta of the Golden Syrian hamster is mediated by receptor-dependent and receptor-independent processes. J Lipid Res 1998, 39:518-530.
22. Desoye G., Schweditsch M.O., Pfeiffer K.P., Zechner R., Kostner G.M. Correlation of hormones with lipid and lipoprotein levels during normal pregnancy and postpartum. J Clin Endocrinol Metab 1987, 64:704-712.
23. Ness R.B., Harris T., Cobb J., et al. Number of pregnancies and the subsequent risk of cardiovascular disease. N Engl J Med 1993, 328:1528-1533.
24. Amundsen A.L., Khoury J., Iversen P.O., et al. Marked changes in plasma lipids and lipoproteins during pregnancy in women with familial hypercholesterolaemia. Atherosclerosis 2006, 189:451-457.
25. Avis H.J., Hutten B.A., Twickler M.T., et al. Pregnancy in women suffering from familial hypercholesterolaemia: a harmful period for both mother and newborn?. Curr Opin Lipidol 2009, 20:484-490.
26. Jasinska M., Owczarek J., Orszulak-Michalak D. Statins: a new insight into their mechanisms of action and consequent pleiotropic effects. Pharmacol Rep 2007, 59:483-499.
27. Werler M.M., Pober B.R., Nelson K., Holmes L.B. Reporting accuracy among mothers of malformed and nonmalformed infants. Am J Epidemiol 1989, 129:415-421.
28. Harteloh P., De Bruin K., Kardaun J. The reliability of cause-of-death coding in The Netherlands. Eur J Epidemiol 2010, 25:531-538.
29. Lakkireddy D.R., Gowda M.S., Murray C.W., Basarakodu K.R., Vacek J.L. Death certificate completion: how well are physicians trained and are cardiovascular causes overstated?. Am J Med 2004, 117:492-498.
30. Van der Graaf A., Vissers M.N., Gaudet D., et al. Dyslipidemia of mothers with familial hypercholesterolemia deteriorates lipids in adult offspring. Arterioscler Thromb Vasc Biol 2010, 30:2673-2677.